Expect Spravato to Be Saved for Hard-to-Treat Depression

August 2020

You'll hear buzz about Spravato (esketamine), a new Rx nasal spray to treat resistant depression in adults.

Spravato is a cousin to ketamine...called "Special K" on the street.

So it's not surprising that Spravato is scheduled as a controlled drug due to risks of misuse and abuse.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Med Safety Clarify Ambiguous Abbreviations
Influenza Have a Game Plan for Flu Vaccines in 2020-21
Infectious Diseases Stay Alert for Dexamethasone Rxs to Prevent or Treat COVID-19
Practice Help Your Pharmacy Team Adapt to Change
Pediatrics Keep Your Radar Up for Kids Getting Risky Meds
Bites & Stings Ensure Patients Get the Right Product for Bug Bites and Stings
Depression Expect Spravato to Be Saved for Hard-to-Treat Depression
Women's Health More Patients Will Ask About Menstrual Cups
Fungal Infections Get a Step Ahead of Mishaps With Toenail Fungus Meds